ZEB2 and neoplasm: For patients with macrophage-enriched tumor samples (n = 67), elevated ZEB2 expressions were significantly related to poor prognosis (hazard ratio = 3.86, 95% CI = 1.08–13.76, logrank p value = 0.025).